You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 5, 2025

Details for Patent: 11,510,878


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,510,878
Title:Extended release multiparticulates of ranolazine
Abstract:The present invention relates to an extended release multiparticulate composition comprising a plurality of discrete units, each discrete unit comprising ranolazine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The said multiparticulate composition is sprinkled onto soft foods or liquids for oral administration. Further, the multiparticulate composition is bioequivalent to the marketed extended release tablet. It further relates to a process of preparation of said multiparticulate composition and method of treatment of patients suffering from angina by administering said composition.
Inventor(s):Singh Harinder, Ahmad Shavej, Singh Romi B.
Assignee:Sun Pharmaceutical Industries Limited
Application Number:US17129167
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 11,510,878

Introduction

When analyzing a U.S. patent, it is crucial to understand the various components that define its scope and claims. This article will delve into the key elements of a U.S. patent, using United States Patent 11,510,878 as an example, to provide a comprehensive overview of the patent landscape.

Structure of a U.S. Patent

A U.S. patent is divided into several sections, each serving a specific purpose.

Document Number and Type

The document number, often prefixed with "US" to indicate it is a U.S. patent, and the type (e.g., B2 for a patent with a previously published application), provide initial identification[1].

Application Number and Date

The application number and the date of application are critical for tracing the patent's history and determining its priority[1].

Date of Patent

The date of patent issuance is important for calculating the patent term and any potential adjustments due to delays in the patent office's response times[1][4].

IPC and National Classification

The International Patent Classification (IPC) and national classification codes help categorize the invention, making it easier to search and compare with other patents in the same field[1].

Title of the Invention

The title is a brief description of the invention, limited to 500 characters or less, providing a quick overview of what the patent covers[1].

References

This section lists prior art, including U.S. and foreign patent documents and other publications cited by the inventor and the patent examiner. These references help establish the novelty and non-obviousness of the invention[1].

Specification

The specification is a detailed written description of the invention.

Description of the Drawings

The specification includes a description of the drawings, which are black and white illustrations that technically detail the invention[1].

Related Prior Art

A discussion of related prior art helps to contextualize the invention within the existing technological landscape[1].

Technical Problem and Solution

The specification explains the specific technical problem the invention solves and how it does so. This is crucial for understanding the invention's purpose and functionality[1].

Preferred Embodiment

The preferred embodiment describes the most favored version of the invention, providing detailed instructions on how to make and use it[1].

Claims

The claims section is perhaps the most critical part of a patent, as it defines the legal boundaries of the invention.

Definition of Claims

Claims are paragraphs located at the end of the specification, preceded by phrases such as “I claim” or “What is claimed.” These claims must be clear and concise, defining what the inventor considers to be the invention[1].

Types of Claims

There are several types of claims, including independent claims, which stand alone, and dependent claims, which refer back to an independent claim. The number of claims can vary widely, from a few to hundreds[1].

Scope of Protection

The claims define the scope of protection for the patent, similar to how a property deed defines the physical boundaries of land. This scope is what distinguishes the invention from prior art and other inventions[1].

Inventorship

Determining who is an inventor is a critical aspect of patent law.

True and Only Inventors

U.S. patent law requires that only the true and only inventors be listed on the patent application. This involves identifying those who conceived the idea and reduced it to practice[2].

Joint Inventors

In cases where multiple individuals collaborate on an invention, joint inventorship applies. Each joint inventor must make a significant contribution to at least one claim in the patent[2].

Patent Landscape and Continuations

The patent landscape can be complex, especially when dealing with continuations and continuations-in-part.

Continuations and Continuations-in-Part

These are types of patent applications that claim priority from an earlier application. Continuations-in-part include new matter not present in the original application, while continuations do not. This can lead to a family of patents with interconnected claims and priority dates[4].

Patent Term Adjustments

Delays in the patent office's response times can result in patent term adjustments, extending the life of the patent. This is particularly relevant for patents that are part of a family with multiple continuations[4].

Economic and Statistical Analysis

The USPTO provides datasets that can be used to analyze patent claims and scope.

Patent Claims Research Dataset

This dataset contains detailed information on claims from U.S. patents granted between 1976 and 2014 and patent applications published between 2001 and 2014. It includes claim-level statistics and document-level statistics, providing insights into patent scope and trends[3].

Legal Considerations and Challenges

Patent claims can be subject to various legal challenges and interpretations.

Obviousness and Novelty

Patent claims must be novel and non-obvious over prior art. Challenges to these claims can arise during reexamination proceedings or in court, where the obviousness of the claims is scrutinized[5].

Office Actions and Reexaminations

The USPTO can issue office actions that challenge the patentability of claims. Reexamination proceedings can also be initiated to review the validity of existing patents, potentially leading to the invalidation of claims[4][5].

Case Studies and Examples

Real-world cases illustrate the complexities and challenges in patent law.

In re Cellect

This case involved a series of patents with interconnected claims and priority dates. The court's decision highlighted the importance of performing an Office Delayed Prosecution (ODP) analysis and the impact of patent term adjustments on the validity of claims[4].

Medtronic vs. Teleflex

In this case, the court analyzed the obviousness of certain claims and the Board's decision to grant motions to amend claims. It underscores the meticulous process of evaluating patent claims and the potential for overlapping sets of claims[5].

Key Takeaways

  • Clear Claims: The claims section is crucial and must clearly define the scope of protection for the patent.
  • Inventorship: Accurately identifying the true and only inventors is essential for maintaining the enforceability of the patent.
  • Patent Landscape: Understanding the relationships between continuations and continuations-in-part is vital for navigating the patent landscape.
  • Legal Challenges: Patents are subject to various legal challenges, including reexamination proceedings and court appeals.
  • Economic Analysis: Utilizing datasets like the Patent Claims Research Dataset can provide valuable insights into patent trends and scope.

FAQs

What is the purpose of the specification in a U.S. patent?

The specification provides a detailed written description of the invention, including descriptions of the drawings, related prior art, the technical problem solved, and the preferred embodiment.

How are claims defined in a U.S. patent?

Claims are paragraphs at the end of the specification that define the legal boundaries of the invention. They must be clear and concise, and there must be at least one claim.

What is joint inventorship in U.S. patent law?

Joint inventorship occurs when two or more people collaborate on an invention, with each person contributing significantly to at least one claim in the patent.

What is the significance of patent term adjustments?

Patent term adjustments extend the life of a patent due to delays in the patent office's response times, ensuring that the patent holder receives the full term of protection.

How can the Patent Claims Research Dataset be used?

The dataset provides detailed information on claims from U.S. patents and applications, allowing for statistical analysis and insights into patent scope and trends.

Sources

  1. Guides.library.queensu.ca: How to Read a U.S. Patent - Patents and Designs - Research Guides.
  2. Agsi.oregonstate.edu: Determining Inventorship for US Patent Applications.
  3. USPTO.gov: Patent Claims Research Dataset.
  4. CAFC.uscourts.gov: In re Cellect - United States Court of Appeals for the Federal Circuit.
  5. CAFC.uscourts.gov: Medtronic - United States Court of Appeals for the Federal Circuit.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,510,878

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Spil ASPRUZYO SPRINKLE ranolazine GRANULES, EXTENDED RELEASE;ORAL 216018-002 Feb 28, 2022 DISCN Yes No ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
Spil ASPRUZYO SPRINKLE ranolazine GRANULES, EXTENDED RELEASE;ORAL 216018-001 Feb 28, 2022 DISCN Yes No ⤷  Try for Free ⤷  Try for Free Y ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 2 of 2 entries

International Family Members for US Patent 11,510,878

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 3409273 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 1 of 1 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.